Related content

Long-Term Results of Melphalan-Based Isolated Limb Perfusion With or Without Low-Dose TNF for In-Transit Melanoma Metastases

By Rossi Carlo  

Annals of Surgical Oncology, Vol. 17, Iss. 11, 2010-11 ,pp. : 3000-3007

Springer Publishing Company

Access to resources Recommend Favorite

Synergistic Antitumor Effects of Histamine Plus Melphalan in Isolated Hepatic Perfusion for Liver Metastases

By Brunstein Flavia   Eggermont Alexander   Wiel-Ambagtsheer Gisela   Tiel Sandra   Rens Joost   Hagen Timo  

Annals of Surgical Oncology, Vol. 14, Iss. 2, 2007-02 ,pp. : 795-801

Springer Publishing Company

Access to resources Recommend Favorite

A Comparison of Dosimetric Methods in Isolated Limb Perfusion with Melphalan for Malignant Melanoma of the Lower Extremity

By Byrne D.S.   McKay A.J.   Blackie R.   MacKie R.M.  

European Journal of Cancer, Vol. 32, Iss. 12, 1996-11 ,pp. : 2082-2087

Elsevier

Access to resources Recommend Favorite

Isolated Limb Perfusion With Melphalan and Tumor Necrosis Factor α for Advanced Melanoma and Soft-Tissue Sarcoma

By Hayes Andrew   Neuhaus Susan   Clark Matthew   Thomas J.  

Annals of Surgical Oncology, Vol. 14, Iss. 1, 2007-01 ,pp. : 230-238

Springer Publishing Company

Access to resources Recommend Favorite

Isolated Limb Perfusion with Tumor Necrosis Factor Alpha and Melphalan for Locally Advanced Soft Tissue Sarcoma: Three Time Periods at Risk for Amputation

By Ginkel Robert   Thijssens Katja   Pras Elisabeth   Graaf Winette   Suurmeijer Albert   Hoekstra Harald  

Annals of Surgical Oncology, Vol. 14, Iss. 4, 2007-04 ,pp. : 1499-1506

Springer Publishing Company

Access to resources Recommend Favorite